AU2003210256A1 - Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) - Google Patents
Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7)Info
- Publication number
- AU2003210256A1 AU2003210256A1 AU2003210256A AU2003210256A AU2003210256A1 AU 2003210256 A1 AU2003210256 A1 AU 2003210256A1 AU 2003210256 A AU2003210256 A AU 2003210256A AU 2003210256 A AU2003210256 A AU 2003210256A AU 2003210256 A1 AU2003210256 A1 AU 2003210256A1
- Authority
- AU
- Australia
- Prior art keywords
- edg7
- therapeutics
- diagnostics
- protein
- diseases associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101001038006 Homo sapiens Lysophosphatidic acid receptor 3 Proteins 0.000 title 1
- 102100040388 Lysophosphatidic acid receptor 3 Human genes 0.000 title 1
- 102100038847 Neuropeptides B/W receptor type 1 Human genes 0.000 title 1
- 101710150346 Neuropeptides B/W receptor type 1 Proteins 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000009762 endothelial cell differentiation Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02004219.8 | 2002-02-26 | ||
| EP02004219 | 2002-02-26 | ||
| PCT/EP2003/001403 WO2003072122A2 (en) | 2002-02-26 | 2003-02-13 | Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003210256A1 true AU2003210256A1 (en) | 2003-09-09 |
| AU2003210256A8 AU2003210256A8 (en) | 2003-09-09 |
Family
ID=27763334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003210256A Abandoned AU2003210256A1 (en) | 2002-02-26 | 2003-02-13 | Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003210256A1 (en) |
| WO (1) | WO2003072122A2 (en) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6242572B1 (en) * | 1997-05-13 | 2001-06-05 | Smithkline Beecham Corporation | Human G protein coupled lysophosphatidic acid receptor |
| CA2230971A1 (en) * | 1997-05-13 | 1998-11-13 | Smithkline Beecham Corporation | G-protein coupled receptor (hofnh30) |
| US6057126A (en) * | 1997-12-24 | 2000-05-02 | Allelix Biopharmaceuticals, Inc. | Mammalian EDG-5 receptor homologs |
| AU1956701A (en) * | 1999-12-10 | 2001-06-18 | Incyte Genomics, Inc. | G-protein coupled receptors |
-
2003
- 2003-02-13 AU AU2003210256A patent/AU2003210256A1/en not_active Abandoned
- 2003-02-13 WO PCT/EP2003/001403 patent/WO2003072122A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003072122A2 (en) | 2003-09-04 |
| AU2003210256A8 (en) | 2003-09-09 |
| WO2003072122A3 (en) | 2004-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003278165A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, lysophosphatidic acid g-protein-coupled receptor 2 (edg2) | |
| AU2002363338A1 (en) | Diagnostics and therapeutics for ocular abnormalities | |
| AU2003210256A1 (en) | Diagnostics and therapeutics for diseases associated with endothelial differentiation lysophosphatic acid g-protein-coupled receptor 7 (edg7) | |
| AU2003273994A1 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
| AU2003298111A1 (en) | Diagnostics and therapeutics for diseases associated with bile acid g-protein-coupled receptor 37 (bg37) | |
| AU2003229767A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9) | |
| AU2003240720A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 5 (sstr5) | |
| AU2003301991A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 5 (edg5) | |
| AU2003276221A1 (en) | Diagnostics and therapeutics for diseases associated with endothelial differentiation, sphingolipid g-protein-coupled receptor 4 (edg4) | |
| AU2003250128A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 37 (gpr37) | |
| AU2003287976A1 (en) | Diagnostics and therapeutics for diseases associated with human endothelial differentiation, sphingolipid g-protein-coupled receptor 3 (edg3) | |
| AU2003216866A1 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 2 (npff2) | |
| AU2003250221A1 (en) | Diagnostics and therapeutics for diseases associated with human cxc chemokine receptor 6(cxcr6) | |
| AU2003288251A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor 38 (gpr38) | |
| AU2003267443A1 (en) | Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 41 (gpr41) | |
| AU2003229753A1 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
| AU2003227064A1 (en) | Diagnostics and therapeutics for diseases associated with neuropeptide ff receptor 1 (npff1) | |
| AU2003212356A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 8 (gpr8) | |
| AU2003227065A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 63 (gpr63) | |
| AU2003254940A1 (en) | CORROSION-RESISTANT Al-BASED STRUCTURAL MEMBER AND METHOD FOR MANUFACTURE THEREOF | |
| AU2003218713A1 (en) | Diagnostics and therapeutics for diseases associated with homo sapiens g - protein - coupled receptor 7 (gpr7) | |
| AU2003221502A1 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 10 (gpr10) | |
| AU2003229736A1 (en) | Diagnostics and therapeutics for diseases associated with neurotensin receptor 1 (nt1) | |
| AU2003240721A1 (en) | Diagnostics and therapeutics for diseases associated with somatostatin receptor 4(sstr4) | |
| AU2003276106A1 (en) | Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |